The aim of the study is to use sequential ultrasound evaluation of the gastric volume to determine how long it takes for the stomach of a fasting pregnant woman at term, admitted for elective cesarean section, to empty after ingesting a 400ml carbohydrate drink (Nutricia preOp).
- Study Type: Interventional
- Study Design
- Intervention Model: Single Group Assignment
- Primary Purpose: Treatment
- Masking: None (Open Label)
- Study Primary Completion Date: January 2019
Recent research suggests that attention to nutrition before operation leads to a speedier recovery through moderating the metabolic responses to surgery, improving well-being, decreasing post-operative insulin resistance and attenuation loss of lean body mass. On other hand there are fasting guidelines in place to prevent from pulmonary aspiration. The current fasting guidelines of 2hrs for clear fluids come from some small studies performed in healthy non-pregnant adults and consensus agreement.
The aim of the study is to use sequential ultrasound evaluation of the gastric volume to determine how long it takes for the stomach of a fasting pregnant woman at term, admitted for elective cesarean section, to empty after ingesting a 400ml carbohydrate drink (Nutricia preOp – a clear, non-carbonated, lemon flavoured, carbohydrate drink that provides 0.5kcal/ml).
Patients who are fasting according to the current guidelines and agree to partake in the study will, on the day of their elective LSCS, be given a 400ml carbohydrate drink at least 2hours before their scheduled theatre time. Patients will then have their gastric volume assessed at 15minutes intervals for 2 hours to determine how long it takes for the ingested fluid to leave the stomach. The results of the study will give us more information regarding gastric emptying in the investigator's patient population and may lead to reduced fasting times, increasing patient comfort and improving the patient experience.
- Dietary Supplement: Nutricia PreOp – a clear, non-carbonated, lemon flavoured, carbohydrate drink that provides 0.5kcal/ml
- Fasting parturients at term, admitted for elective cesarean section and consent to partake in the study, will be given the intervention drink
Arms, Groups and Cohorts
- Other: Fasting parturients at term
- Fasting parturients at term, admitted for elective cesarean section, who consent to partake in the study
Clinical Trial Outcome Measures
- Time interval required to return to the fasting grade.
- Time Frame: 2 hours
- The stomach will be scanned and graded (Perlas grade 0-2) every 15 minutes based on the presence or absence of clear fluid in supine and right lateral decubitus position at 45 degrees elevation of the upper body, after consumption of 400 ml clear carbohydrate drink (Nutricia PreOp).
- Number of participants with grade 0, 1 and 2 in fasting term parturients attending for elective cesarean section
- Time Frame: 10 minutes
- Initial “fasting” scan will be performed in all patients
- Time taken for the antral cross sectional area (measured by ultrasound) to reach <9.6 cm2 (suggested cut off value for ingested volumes < 1.5ml.kg-1) after ingesting 400 ml carbohydrate drink
- Time Frame: 2 hours
- Sequential ultrasound scans will be performed at 15 min intervals for 2 hours.
- Antral cross sectional area at 2 hours
- Time Frame: 2 hours
- Ultrasound measurement of antral cross sectional area will be performed at 2 hours after consumption of 400 ml clear carbohydrate drink (Nutricia PreOp).
Participating in This Clinical Trial
- Elective LSCS
- gestation >38 gestation weeks
- Multiple pregnancy
- Previous upper GI surgery
- Known disorder of gastric emptying
- Hiatus Hernia
- BMI >40
- Diabetes Mellitus, Gestational Diabetes
Gender Eligibility: Female
Minimum Age: 18 Years
Maximum Age: 50 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
- Lead Sponsor
- Coombe Women and Infants University Hospital
- Provider of Information About this Clinical Study
- Principal Investigator: Petar Popivanov, Consultant Anaesthetist – Coombe Women and Infants University Hospital
- Overall Contact(s)
- Petar Popivanov, +353 (01) 4085662, email@example.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.